Daniel Leslie, MD

Daniel Leslie, MD, is an Associate Professor and Chief of the Division of GI/Bariatric Surgery in the Department of Surgery at the University of Minnesota, the system-wide Director of the Comprehensive Weight Management Program for University of Minnesota Health/Fairview, and the Medical Director for CentraCare Weight Management. He completed his medical degree at the University of Medicine and Dentistry of New Jersey, followed by a residency and fellowship in General Surgery and Minimally Invasive Surgery at the University of Minnesota. He has been on staff at the University of Minnesota since 2007. He is a member of the American Society of Metabolic and Bariatric Surgery (ASMBS) and has board certification in surgery (ABS) and obesity medicine (ABOM).

Academically, Dr. Leslie has co-authored five book chapters and has authored or co-authored over fifty peer-reviewed publications. He has presented dozens of abstracts locally, nationally, and internationally. He has an active interest in diabetes and cardiovascular risk reduction after bariatric procedures, as well as novel interventions to treat bariatric patients.

• Fellow, American College of Surgeons
• Member, Society of American Gastrointestinal and Endoscopic Surgeons
• American Society for Metabolic & Bariatric Surgery
  
• Representative, Graduate Medical Education Committee, University of Minnesota (1999-2000)

• Leslie DB, Dorman RB, Anderson J, et al. Routine upper gastrointestinal imaging is superior to clinical signs for detecting gastrojejunal leak after laparoscopic roux-en-y gastric bypass. J Am Coll Surg. 2012;214(2):208-213. doi:10.1016/j.jamcollsurg.2011.10.021.
• Leslie DB, Dorman RB, Serrot FJ, et al. Efficacy of the Roux-en-Y gastric bypass compared to medically managed controls in meeting the American Diabetes Association composite end point goals for management of type 2 diabetes mellitus. Obes Surg. 2012;22(3):367-374. doi:10.1007/s11695-011-0494-y.
• Attam R, Leslie D, Arain M, Freeman M, Ikramuddin S. EUS-guided sutured gastropexy for transgastric ERCP (ESTER) in patients with Roux-en-Y gastric bypass: a novel, single-session, minimally invasive approach. Endoscopy. 2015;47(07):646-649. doi:10.1055/s-0034-1391124.
• Ikramuddin S, Billington CJ, Lee W-J, Bantle JP, Thomas AV, Connett JE, Leslie DB, et al. Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial. Lancet Diabetes Endocrinol. 2015;3(6):413-422. doi:10.1016/S2213-8587(15)00089-3.
• Jahansouz C, Serrot FJ, Frohnert BI, Foncea RE, Dorman RB, Slusarek B, Leslie DB, et al. Roux-en-Y Gastric Bypass Acutely Decreases Protein Carbonylation and Increases Expression of Mitochondrial Biogenesis Genes in Subcutaneous Adipose Tissue. Obes Surg. May 2015. doi:10.1007/s11695-015-1708-5.